Breakthrough on the Horizon for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients (Part 2 of 2)

Read Part 1 Along with debilitating fatigue, Myalgic Encephalomyelitis (ME) and Chronic Fatigue Syndrome (CFS) patients suffer from neurocognitive issues such as difficulty processing information, impaired memory, poor concentration and challenges with locating words and speaking. Abnormal sleep patterns are present, causing interrupted and ineffective sleep. Gastrointestinal problems, such as irritable bowel syndrome, bacterial infections and candida are also common. Additionally, cardiovascular symptoms such as palpitations and arrhythmias are noted, along with hypotension – low blood pressure – and postural orthostatic tachycardia syndrome (POTS). Problems with temperature regulation, swollen lymph glands, impaired vision, light sensitivity, sensitivities to certain foods and chemicals, muscle weakness and poor coordination are all hallmark symptoms of the illness. Tremors, seizures and paralysis have also been documented in ME/CFS patients. Studies have consistently shown compromised mitochondria function in ME/CFS, which is why avoiding overexertion is so